Lynde Quirk
Family · Grand Forks, NDNPI 1467159038
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,496 of the $4,615 with a category attached, or 75.8%. Medtronic accounts for 88.1% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $2,286, more than ten times the $117 reported in 2023. Among family clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 33 payments — averaging $139.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- AstraZeneca$188
- UCB, Inc.$117
- Biogen$98
- Springworks Therapeutics, Inc.$77
- SK Life Science, Inc.$50
- plus $21 from 1 others
What the payments were for
- Travel & lodging$3,49676%
- Food & beverage$1,11924%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 23 | $4,064 |
| AstraZeneca(2 entities) | 3 | $188 |
| UCB, Inc. | 3 | $117 |
| Biogen | 1 | $98 |
| Springworks Therapeutics, Inc. | 1 | $77 |
| SK Life Science, Inc. | 1 | $50 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
How this compares
$4,615 in reported general payments places this provider in the 95th percentile of 496 family providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $17,605 |
| Emgality PenGalcanezumab-Gnlm | 11 | $9,593 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 12 | $8,654 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 53 | $1,513 |
| Duloxetine Hcl | 29 | $944 |
| Pregabalin | 39 | $441 |
| Primidone | 19 | $378 |
| Gabapentin | 59 | $372 |
| Levetiracetam | 21 | $355 |
| Rosuvastatin Calcium | 18 | $147 |
| Topiramate | 14 | $89 |
Paid to pharmacies, not to this prescriber.
Other family in Grand Forks
- Coralyn Jensen KurtzGrand Forks$12K
- Paula RickeGrand Forks$9K
- Leanne KilzerGrand Forks$3K
- Nicole RobinsonGrand Forks$2K
- Nicole StrausGrand Forks$2K
- Christina DahlJamestown$26K
- Courtney WoodburyBismarck$8K
- Monica GoetzBismarck$8K
- Danielle EidenschinkFargo$6K
- Chantel HillestadMinot$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.